Search
Kiniksa Pharmaceuticals International PLC
KNSAAdd to Watchlist
59.910USD
+0.420+0.71%
Market hours （ET）Quotes delayed by 15 min
4.61BMarket Cap
61.58P/E TTM
Kiniksa Pharmaceuticals International PLC Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
677.56M
60.09%
EPS(YoY)
0.80
231.50%
Analyst Rating
BUY
2026-06-23
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its total revenue reached 677.56M, with a year-on-year change of 60.09.
What are the current assets of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its current assets were 527.18M, with a year-on-year change of 58.88.
What are the total assets of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its total assets of Kiniksa Pharmaceuticals International PLC were 763.63M, with a year-on-year change of 31.54.
What are the total liabilities of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its total liabilities of Kiniksa Pharmaceuticals International PLC were 196.03M, with a year-on-year change of 37.93.
What is the total equity of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its total equity of Kiniksa Pharmaceuticals International PLC was 567.61M, with a year-on-year change of 29.46.
What is the net investment of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its net investment of Kiniksa Pharmaceuticals International PLC was -188.99M, with a year-on-year change of -601.68.
What is the net financing of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its net financing of Kiniksa Pharmaceuticals International PLC was 33.02M, with a year-on-year change of 169.22.
What is the Earnings Per Share (EPS) of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its Earnings Per Share (EPS) was 0.80, with a year-on-year change of 231.50.
What is the net margin of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its net profit margin was 8.71, with a year-on-year change of 185.33.
What is the gross margin of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its gross margin was 88.54, with a year-on-year change of 3.42.
What is the Return on Equity (ROE) of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its Return on Equity (ROE) was 11.73, with a year-on-year change of 219.12.
What is the Return on Assets (ROA) of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its Return on Assets (ROA) was 8.78, with a year-on-year change of 212.49.
What is the operating profit of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its operating profit was 77.22M, with a year-on-year change of 269.28.
